Canada Pension Plan Investment Board
CTMX icon

Canada Pension Plan Investment Board’s CytomX Therapeutics CTMX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$511K Buy
108,800
+4,600
+4% +$23.3K ﹤0.01% 1229
2025
Q4 		$444K Buy
+104,200
New +$396K ﹤0.01% 1344

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Canada Pension Plan Investment Board's CTMX Position: Q1 2026 in Review

Canada Pension Plan Investment Board increased its CytomX Therapeutics (CTMX) stake by 4.4% in Q1 2026, buying an estimated $23.3K and bringing the position to 108,800 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #1229.

Canada Pension Plan Investment Board first reported a position in CTMX in Q4 2025 and has held it in 2 quarters since. 179 funds tracked by Wall St. Rank hold CTMX as of Q1 2026.

  • Canada Pension Plan Investment Board held 108,800 shares of CytomX Therapeutics worth $511K as of Q1 2026.
  • Canada Pension Plan Investment Board bought 4,600 CytomX Therapeutics shares in Q1 2026, an estimated $23.3K.
  • CytomX Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1229 holding.
  • Canada Pension Plan Investment Board first reported a position in CytomX Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 179 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.